Darlise DiMatteo

2PUBLICATIONS
13CO-AUTHORS
Molecular targetsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Sep 10, 2024
Selective targeting of mutated calreticulin by the monoclonal antibody INCA033989 inhibits oncogenic function of MPN.

Edimara S Reis, Rebecca Buonpane, Hamza Celik

|Mar 07, 2022
Characterization of INCB086550: A Potent and Novel Small-Molecule PD-L1 Inhibitor.

Holly K Koblish, Liangxing Wu, Liang-Chuan S Wang

Pageof 1

Frequent Collaborators

1 joint publications

Holly K Koblish

1 joint publications

Jonathan Rios-Doria

1 joint publications

Rebecca Buonpane

1 joint publications

Caroline Marty

1 joint publications

Florence Pasquier

1 joint publications

Guillemette Fouquet

1 joint publications

William Vainchenker

1 joint publications

Yan-Ou Yang

1 joint publications

Shaun Stewart

1 joint publications

Ian S Hitchcock

Frequent Collaborators

1 joint publications

Holly K Koblish

1 joint publications

Jonathan Rios-Doria

1 joint publications

Rebecca Buonpane

1 joint publications

Caroline Marty

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells
10:21

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Published on : Jan 05, 2018

13.1K
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

587
See more related videos

Top Related Videos

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells
10:21

Using CRISPR/Cas9 Gene Editing to Investigate the Oncogenic Activity of Mutant Calreticulin in Cytokine Dependent Hematopoietic Cells

Published on : Jan 05, 2018

13.1K
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on : May 02, 2025

587
See more related videos